BPB
ACGN

Badgley, Phelps & Bell’s Aceragen Inc ACGN Stock Holding History

Badgley, Phelps & Bell’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-147
Closed -$26K – 191
2018
Q2 		$26K Hold
147
– – ﹤0.01% 179
2018
Q1 		$37K Hold
147
– – ﹤0.01% 187
2017
Q4 		$42K Buy
+147
New +$42K ﹤0.01% 194

Other funds holding ACGN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Badgley, Phelps & Bell's ACGN Position: Q3 2018 in Review

Badgley, Phelps & Bell sold out of Aceragen Inc (ACGN) in Q3 2018, closing a stake of 147 shares — an estimated $26K sold.

Badgley, Phelps & Bell first reported a position in ACGN in Q4 2017 and held it in 3 quarters. The position peaked at $42K in Q4 2017. 72 funds tracked by Wall St. Rank hold ACGN as of Q3 2018.

  • Badgley, Phelps & Bell reported no remaining Aceragen Inc position as of Q3 2018 after selling out during the quarter.
  • Badgley, Phelps & Bell sold 147 Aceragen Inc shares in Q3 2018, an estimated $26K.
  • Badgley, Phelps & Bell first reported a position in Aceragen Inc in Q4 2017 and held it in 3 quarters.
  • Badgley, Phelps & Bell's Aceragen Inc position peaked at $42K in Q4 2017.
  • 72 funds tracked by Wall St. Rank held Aceragen Inc as of Q3 2018.

Based on Badgley, Phelps & Bell's 13F filing for Q3 2018, filed 9 Nov 2018.